Stopped: Inability to recruit further patients for study
Short gut syndrome with intestinal failure patients may have decreased production of disaccharidases, like sucrase, an enzyme responsible for digesting sugar in foods. This can happen due to loss of bowel length from surgery or from loss of cellular function in the intestines due to use of parenteral nutrition intravenously. Therefore, patients with these conditions may not be able to digest sucrose (sugar) fully. Patients might experience abdominal distension/pain, vomiting and diarrhea when sugar is taken in orally or through the g-tube, which can limit patients' ability to increase oral or g-tube feeds in short gut syndrome patients with intestinal failure. In patients with short gut syndrome and intestinal failure, the administration of exogenous sucrase (enzyme) may improve sucrose (sugar) digestion and thus the ability to tolerate more oral or g-tube feeds.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Change in Carbohydrate Malabsorption
Timeframe: baseline, 9 weeks
Change in Carbohydrate Malabsorption as Measured by Patient Symptom Survey
Timeframe: baseline, 9 weeks
Change in Carbohydrate Malabsorption as Measured by Growth Velocity
Timeframe: baseline, 9 weeks
Change in Carbohydrate Malabsorption as Measured by Enteral Nutrition Tolerance
Timeframe: baseline, 9 weeks